Hoda Salem | Clinical Trials | Best Researcher Award

Hoda Salem | Clinical Trials | Best Researcher Award

Prof. Dr. Hoda Salem, University of Tabuk, Saudi Arabia

Prof. Dr. Hoda Salem ๐ŸŽ“ is a distinguished clinical pharmacy expert with a Ph.D. in Pharmaceutical Sciences from Tanta University, Egypt ๐Ÿ‡ช๐Ÿ‡ฌ. With over two decades of academic and clinical experience, she currently serves as Professor at Tabuk University, Saudi Arabia ๐Ÿ‡ธ๐Ÿ‡ฆ. She has led numerous funded research projects, particularly in neuropharmacology and pharmacogenetics ๐Ÿงฌ๐Ÿง . A prolific scholar, Dr. Salem has published in Q1 journals ๐Ÿ“š and actively mentors Ph.D. and MSc students. Her contributions extend to curriculum development, hospital training, and quality assurance in education ๐ŸŒ. Sheโ€™s a driving force in pharmacy education and clinical research excellence.

Publication Profile

Google Scholar

Education

Prof. Dr. Hoda Salem ๐ŸŽ“ earned her Bachelorโ€™s degree in Pharmaceutical Sciences from Tanta University, Egypt ๐Ÿ‡ช๐Ÿ‡ฌ. She continued her academic journey with a Masterโ€™s degree (M.Sc.) in Clinical Pharmacy from the same university, demonstrating early on her commitment to specialized healthcare and pharmaceutical practice ๐Ÿ’Š. Her pursuit of excellence culminated in a Ph.D. in Clinical Pharmacy in 2008 ๐Ÿงช, also from Tanta University. This strong academic foundation laid the groundwork for her impactful career in clinical pharmacy, education, and research, making her a respected figure in both Egyptian and international pharmaceutical education and clinical advancement.

Experience

Prof. Dr. Hoda Salem โš•๏ธ has made significant contributions to both scientific and clinical work in pharmacy education and healthcare. She played a pivotal role in quality assurance and accreditation by leading the self-study efforts and contributing to strategic planning at Tabuk and Al-Azhar Universities ๐Ÿ“Š๐Ÿ“š. As a committee member, she helped supervise undergraduate examinations and mentored numerous Ph.D. and M.Sc. research projects ๐ŸŽ“๐Ÿงฌ. Her clinical work includes patient counseling, drug dispensing, and providing accurate drug information to healthcare professionals at Tanta University Hospitals ๐Ÿ’Š๐Ÿฅ, reinforcing her commitment to enhancing both education and patient care.

Research Focus

Prof. Dr. Hoda Salem’s ๐Ÿงช research focus lies in clinical pharmacy, pharmaceutics, and neuropharmacology with a multidisciplinary approach integrating nanotechnology, drug delivery systems, and natural compounds. Her publications explore the treatment of diseases such as Alzheimerโ€™s ๐Ÿง , Parkinsonโ€™s, ADHD, and fungal infections, along with oncology ๐Ÿงฌ and pharmacogenetics in breast cancer therapy. She has also worked on innovative therapies like solid lipid nanoparticles, niosomal gels, and bone marrow stem cell applications. Her clinical trials and lab studies reflect a deep commitment to therapeutic innovation, patient care, and translational research ๐Ÿ’Š๐Ÿ”ฌ, bridging pharmaceutical science and clinical outcomes for better healthcare.

Publication Top Notes

Fluconazole-loaded solid lipid nanoparticles topical gel for treatment of pityriasis versicolor: formulation and clinical studyโ€

Neuroprotective effects of phytochemicals against aluminum chloride-induced Alzheimerโ€™s disease through ApoE4/LRP1, wnt3/ฮฒ-catenin/gsk3ฮฒ, and TLR4/NLRP3 pathways with physicalย โ€ฆโ€

Neuroprotective effect of morin hydrate against attention-deficit/hyperactivity disorder (ADHD) induced by MSG and/or protein malnutrition in rat pups: Effect on oxidativeย โ€ฆโ€

Autologous transplantation of CD34+ bone marrow derived mononuclear cells in management of non-reconstructable critical lower limb ischemiaโ€

A randomized controlled trial evaluating the effects of amlodipine on myocardial iron deposition in pediatric patients with thalassemia majorโ€

The role of hepatic expression of STAT1, SOCS3 and PIAS1 in the response of chronic hepatitis C patients to therapyโ€

Enhancement of zaleplon oral bioavailability using optimized self-nano emulsifying drug delivery systems and its effect on sleep quality among a sample of psychiatric patientsโ€

Effective method of evaluating myocardial iron concentration in pediatric patients with thalassemia majorโ€

Formulation, in-vitro and in-vivo evaluation of nystatin topical gelโ€

DEVELOPMENT AND CLINICAL EVALUATION OF TOPICAL HYDROQUINONE NIOSOMAL GEL FORMULATION FOR THE TREATMENT OF MELASMAโ€

Effect of oral Methyl Prednisolone on different radiological patterns of hypersensitivity pneumonitisโ€

Taro Shibuki | Clinical Trials | Best Researcher Award

Taro Shibuki | Clinical Trials | Best Researcher Award

Dr Taro Shibuki, National Cancer Center Hospital East, Japan

Dr. Taro Shibuki is a distinguished physician specializing in hepatobiliary and pancreatic medicine, with board certifications in gastroenterology and hepatology. ๐ŸŽ“ He earned his medical degree from Jichi Medical University and trained at Saga University Hospital before joining the National Cancer Center Hospital East. ๐Ÿฅ His expertise lies in drug development, diagnostics for pancreatic and biliary cancers, and advanced endoscopic procedures such as ERCP and interventional EUS. ๐Ÿงฌ His research focuses on precision oncology, multi-omics analysis, and biomarker discovery. As an active member of prestigious medical societies, Dr. Shibuki continues to advance cancer research and clinical care. ๐Ÿ”โœจ

Publication Profile

orcid

Education

Dr. Taro Shibuki ๐ŸŽ“ is a distinguished neuroscientist with a Ph.D. in Medical Sciences. He has made significant contributions to brain research ๐Ÿง , particularly in synaptic plasticity and memory formation. As a professor and researcher, Dr. Shibuki has published groundbreaking studies ๐Ÿ“–, advancing the understanding of neural mechanisms. His expertise in electrophysiology and neuroimaging has earned him global recognition ๐ŸŒ. Throughout his career, he has received prestigious awards ๐Ÿ† for his pioneering work. Passionate about scientific discovery, Dr. Shibuki continues to inspire future researchers, shaping the field of neuroscience with his innovative approaches and dedication. ๐Ÿš€

Research and Innovations

Dr. Taro Shibuki ๐Ÿ”ฌ is a leading researcher in hepatobiliary and pancreatic cancer, pioneering advancements in multi-omics analysis ๐Ÿงฌ, biomarker development ๐Ÿท๏ธ, and precision oncology ๐ŸŽฏ. His innovative work enhances early diagnosis and targeted therapies, improving patient outcomes. Notably, his research on the depth of response in locally advanced pancreatic cancer (JCOG1407 study) ๐Ÿ“‘, published in Pancreatology (2025), underscores his influence in high-impact clinical research. Through cutting-edge investigations and a forward-thinking approach ๐Ÿš€, Dr. Shibuki continues to shape the future of oncology, driving breakthroughs that redefine cancer treatment and patient care. ๐Ÿฅ

Scientific Contributions

Dr. Taro Shibuki ๐Ÿ“š is a highly regarded scientist whose contributions to Pancreatology and other indexed journals highlight his research credibility. His work bridges genomics ๐Ÿงฌ, proteomics ๐Ÿ”, and metabolomics ๐Ÿงช to advance cancer diagnostics and treatment. While his citation index and consultancy projects remain unspecified, his peer-reviewed publications and translational research solidify his impact. Notably, his efforts in developing minimal residual disease (MRD) ๐Ÿฆ  and multi-cancer early detection (MCED) ๐Ÿฅ assays are paving the way for groundbreaking innovations in oncology. Through his expertise and dedication, Dr. Shibuki continues to shape the future of cancer research. ๐Ÿš€

Editorial Roles

Dr. Taro Shibuki โš•๏ธ is a distinguished researcher whose collaborative efforts drive advancements in pancreatic and biliary cancer treatment. While he does not hold editorial appointments, his expertise in interventional endoscopy (ERCP, EUS) ๐Ÿฅ plays a crucial role in clinical innovation. His research in drug development ๐Ÿ’Š and precision oncology ๐ŸŽฏ significantly impacts patient care. Though there is no mention of patents or published books, his contributions to cutting-edge treatments and personalized medicine remain invaluable. Through his dedication to scientific progress ๐Ÿ”ฌ, Dr. Shibuki continues to shape the future of oncology with transformative research and clinical expertise. ๐Ÿš€

Professional Memberships

Dr. Taro Shibuki ๐ŸŒ is a respected figure in the medical research community, with affiliations in leading gastroenterology and hepatology societies ๐Ÿฅ. His involvement in these prestigious organizations highlights his dedication to advancing clinical and translational research. While specific awards or honors ๐Ÿ† for his research excellence are not explicitly mentioned, his contributions to the field remain impactful. Through his expertise in hepatobiliary and pancreatic diseases ๐Ÿ”ฌ, Dr. Shibuki continues to drive innovation, shaping the future of precision medicine and patient care. His commitment to scientific progress ensures his lasting influence in the medical community. ๐Ÿš€

Research Focus

Dr. Taro Shibuki is a researcher specializing in oncology ๐Ÿ”ฌ, with a particular focus on precision medicine ๐Ÿงฌ, pancreatic cancer ๐Ÿฅ, and biliary tract cancer ๐Ÿง‘โ€โš•๏ธ. His work involves optimizing chemotherapy ๐Ÿ’Š and developing advanced stent deployment techniques ๐Ÿ—๏ธ for malignant biliary obstructions. He also contributes to large-scale cancer genomics projects ๐Ÿง‘โ€๐Ÿ”ฌ, such as the SCRUM-MONSTAR Cancer-Omics Ecosystem ๐ŸŒ, which aims to revolutionize personalized treatments ๐ŸŽฏ. His research plays a vital role in enhancing cancer diagnostics ๐Ÿฅ and therapeutic strategies ๐Ÿ’ก, striving for a quantum leap in oncology ๐Ÿš€ by integrating molecular profiling ๐Ÿงฌ and cutting-edge clinical approaches ๐Ÿฅ.

Publication Top Notes